The Claim
Oral administration of selenomethionine at a dose of 3 mg/kg reduces serum creatinine, blood urea nitrogen, and malondialdehyde levels and improves histological kidney damage in mice with cisplatin-induced acute kidney injury, and these effects are correlated with increased renal glutathione peroxidase 4 levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice with kidney injury caused by cisplatin, taking selenomethionine by mouth lowers levels of biomarkers associated with kidney damage and improves tissue appearance under a microscope, which is linked to higher levels of the enzyme GPX4 in the kidneys.
See the scientific wording
Oral administration of selenomethionine (3 mg/kg) reduces markers of kidney injury (serum creatinine, BUN, MDA) and improves histological damage in mice with cisplatin-induced acute kidney injury, correlating with increased renal GPX4 levels.
What the research says
1 studyGiving mice a selenium-containing compound called selenomethionine helped protect their kidneys from damage caused by a chemotherapy drug, by boosting a natural antioxidant enzyme and reducing harmful oxidative stress.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.